Mineralys Therapeutics, Inc. MLYS Number of Vested and Expected to Vest Options
Number of Vested and Expected to Vest Options at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue.
The official record: Mineralys Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s number of vested and expected to vest options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s number of vested and expected to vest options?
- Mineralys Therapeutics, Inc. (MLYS) reported number of vested and expected to vest options of $32.3M in Q4 2025.
- What does number of vested and expected to vest options mean?
- This metric represents the total number of share-based payment awards that have either met their service requirements or are projected to meet them based on current employment trends. It serves as a key indicator of potential future dilution for shareholders and reflects the scale of equity-based compensation utilized to incentivize talent. Investors monitor this to assess the long-term impact of stock-based compensation on earnings per share and overall equity structure.